Bellwether Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Buy
+3,145
New +$1.26M 0.18% 102
2025
Q3
– Sell
-4
Closed -$1.56K – 271
2025
Q2
$1.56K Hold
4
– – ﹤0.01% 510
2025
Q1
$1.74K Hold
4
– – ﹤0.01% 442
2024
Q4
$1.48K Buy
+4
New +$1.67K ﹤0.01% 465
2023
Q2
– Sell
-4
Closed -$1.84K – 202
2023
Q1
$1.84K Hold
4
– – ﹤0.01% 348
2022
Q4
$2.05K Sell
4
-1
-20% -$508 ﹤0.01% 355
2022
Q3
$2K Buy
5
+1
+25% +$478 ﹤0.01% 382
2022
Q2
$1K Hold
4
– – ﹤0.01% 353
2022
Q1
$1K Hold
4
– – ﹤0.01% 498
2021
Q4
$1K Sell
4
-4
-50% -$1.68K ﹤0.01% 526
2021
Q3
$2K Buy
8
+4
+100% +$1.52K ﹤0.01% 465
2021
Q2
$1K Hold
4
– – ﹤0.01% 395
2021
Q1
$1K Hold
4
– – ﹤0.01% 370
2020
Q4
$1K Buy
+4
New +$1.23K ﹤0.01% 311

Other funds holding ELV

Bellwether Advisors's ELV Position: Q3 2026 in Review

Bellwether Advisors opened a new position in Elevance Health (ELV) in Q3 2026: 3,145 shares worth $1.22M. The stake represents 0.18% of the portfolio and ranks #102 among its holdings. This is a return to the name: Bellwether Advisors previously reported a position in ELV as recently as Q2 2025.

Bellwether Advisors first reported a position in ELV in Q4 2020 and has held it in 14 quarters since. 1,031 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Bellwether Advisors held 3,145 shares of Elevance Health worth $1.22M as of Q3 2026.
  • Elevance Health was a new Bellwether Advisors position in Q3 2026.
  • Elevance Health made up 0.18% of Bellwether Advisors's portfolio in Q3 2026, its #102 holding.
  • Bellwether Advisors first reported a position in Elevance Health in Q4 2020 and has held it in 14 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Bellwether Advisors's 13F filing for Q3 2026, filed 9 Nov 2026.